Adooq Bioscience

Adooq Bioscience logo

AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.

Company Website

Product Listing

DCC-2618 10mg 10mg  | Purity Not Available

Adooq Bioscience

DCC-2618 is a small molecule inhibitor of c-Kit and PDGFR with IC50s of 6 nM/30 nM/13 nM for c-Kit/PDGFR??/PDGFR?? respectively.

More Information Supplier Page

DCC-2618 50mg 50mg  | Purity Not Available

Adooq Bioscience

DCC-2618 is a small molecule inhibitor of c-Kit and PDGFR with IC50s of 6 nM/30 nM/13 nM for c-Kit/PDGFR??/PDGFR?? respectively.

More Information Supplier Page

DCC-2618 5mg 5mg  | Purity Not Available

Adooq Bioscience

DCC-2618 is a small molecule inhibitor of c-Kit and PDGFR with IC50s of 6 nM/30 nM/13 nM for c-Kit/PDGFR??/PDGFR?? respectively.

More Information Supplier Page

DDR1-IN-1 10mg 10mg  | Purity Not Available

Adooq Bioscience

DDR1-IN-1 is a potent and selective DDR1 receptor tyrosine kinase inhibitor with IC50/EC50 of 105 nM/87 nM, 4-fold less potent for DDR2 (IC50= 413 nM).

More Information Supplier Page

DDR1-IN-1 25mg 25mg  | Purity Not Available

Adooq Bioscience

DDR1-IN-1 is a potent and selective DDR1 receptor tyrosine kinase inhibitor with IC50/EC50 of 105 nM/87 nM, 4-fold less potent for DDR2 (IC50= 413 nM).

More Information Supplier Page

DDR1-IN-1 5mg 5mg  | Purity Not Available

Adooq Bioscience

DDR1-IN-1 is a potent and selective DDR1 receptor tyrosine kinase inhibitor with IC50/EC50 of 105 nM/87 nM, 4-fold less potent for DDR2 (IC50= 413 nM).

More Information Supplier Page

Debio-1347 10mg 10mg  | Purity Not Available

Adooq Bioscience

Debio-1347 is an orally bioavailable inhibitor of the fibroblast growth factor receptor subtypes 1 (FGFR-1), 2 (FGFR-2) and 3 (FGFR-3), with potential antineoplastic activity.

More Information Supplier Page

Debio-1347 25mg 25mg  | Purity Not Available

Adooq Bioscience

Debio-1347 is an orally bioavailable inhibitor of the fibroblast growth factor receptor subtypes 1 (FGFR-1), 2 (FGFR-2) and 3 (FGFR-3), with potential antineoplastic activity.

More Information Supplier Page

Debio-1347 5mg 5mg  | Purity Not Available

Adooq Bioscience

Debio-1347 is an orally bioavailable inhibitor of the fibroblast growth factor receptor subtypes 1 (FGFR-1), 2 (FGFR-2) and 3 (FGFR-3), with potential antineoplastic activity.

More Information Supplier Page

Deferasirox 10mg 10mg  | Purity Not Available

Adooq Bioscience

Deferasirox is a rationally-designed oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias.

More Information Supplier Page

Deferasirox 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

Deferasirox is a rationally-designed oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias.

More Information Supplier Page

Deferasirox 25mg 25mg  | Purity Not Available

Adooq Bioscience

Deferasirox is a rationally-designed oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias.

More Information Supplier Page

Deferasirox 50mg 50mg  | Purity Not Available

Adooq Bioscience

Deferasirox is a rationally-designed oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias.

More Information Supplier Page

Deferasirox 5mg 5mg  | Purity Not Available

Adooq Bioscience

Deferasirox is a rationally-designed oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias.

More Information Supplier Page

Deferasirox Fe3+ chelate 10mg 10mg  | Purity Not Available

Adooq Bioscience

Deferasirox Fe3+ chelate is a rationally-designed oral iron chelator; its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias.

More Information Supplier Page

Deferasirox Fe3+ chelate 50mg 50mg  | Purity Not Available

Adooq Bioscience

Deferasirox Fe3+ chelate is a rationally-designed oral iron chelator; its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias.

More Information Supplier Page

Deferasirox Fe3+ chelate 5mg 5mg  | Purity Not Available

Adooq Bioscience

Deferasirox Fe3+ chelate is a rationally-designed oral iron chelator; its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias.

More Information Supplier Page

Deforolimus (Ridaforolimus) 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

Deforolimus (Ridaforolimus) is an investigational targeted and small-molecule inhibitor of the protein mTOR, a protein that acts as a central regulator of protein synthesis, cell proliferation, cell cycle progression and cell survival, integrating signals from proteins, such as PI3K, AKT and PTEN known to be important to malignancy. Blocking mTOR creates a starvation-like effect in […]

More Information Supplier Page

Deforolimus 100mg 100mg  | Purity Not Available

Adooq Bioscience

Deforolimus (Ridaforolimus) is an investigational targeted and small-molecule inhibitor of the protein mTOR, a protein that acts as a central regulator of protein synthesis, cell proliferation, cell cycle progression and cell survival, integrating signals from proteins, such as PI3K, AKT and PTEN known to be important to malignancy. Blocking mTOR creates a starvation-like effect in […]

More Information Supplier Page

Deforolimus 10mg 10mg  | Purity Not Available

Adooq Bioscience

Deforolimus (Ridaforolimus) is an investigational targeted and small-molecule inhibitor of the protein mTOR, a protein that acts as a central regulator of protein synthesis, cell proliferation, cell cycle progression and cell survival, integrating signals from proteins, such as PI3K, AKT and PTEN known to be important to malignancy. Blocking mTOR creates a starvation-like effect in […]

More Information Supplier Page

Deforolimus 50mg 50mg  | Purity Not Available

Adooq Bioscience

Deforolimus (Ridaforolimus) is an investigational targeted and small-molecule inhibitor of the protein mTOR, a protein that acts as a central regulator of protein synthesis, cell proliferation, cell cycle progression and cell survival, integrating signals from proteins, such as PI3K, AKT and PTEN known to be important to malignancy. Blocking mTOR creates a starvation-like effect in […]

More Information Supplier Page

Deforolimus 5mg 5mg  | Purity Not Available

Adooq Bioscience

Deforolimus (Ridaforolimus) is an investigational targeted and small-molecule inhibitor of the protein mTOR, a protein that acts as a central regulator of protein synthesis, cell proliferation, cell cycle progression and cell survival, integrating signals from proteins, such as PI3K, AKT and PTEN known to be important to malignancy. Blocking mTOR creates a starvation-like effect in […]

More Information Supplier Page